AU Stock MarketDetailed Quotes

OncoSil Medical Ltd (OSLO)

Watchlist
  • 0.020
  • +0.010+100.00%
20min DelayNot Open May 6 11:24 AET
613.94KMarket Cap0.00P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OncoSil Medical Ltd (OSLO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
(FY)Jun 30, 2018
(FY)Jun 30, 2017
(FY)Jun 30, 2016
Total revenue
126.62%1.17M
40.51%516.63K
58.63%367.68K
8.79%231.79K
213.07K
Operating revenue
126.62%1.17M
40.51%516.63K
58.63%367.68K
8.79%231.79K
--213.07K
----
----
----
----
----
Cost of revenue
49.27%2.25M
-4.97%1.51M
63.37%1.59M
1.19%972.47K
961.02K
Gross profit
-9.03%-1.08M
18.67%-993.12K
-64.86%-1.22M
0.97%-740.69K
-747.95K
Operating expense
19.22%14.41M
5.00%12.08M
6.60%11.51M
-2.43%10.8M
50.35%11.06M
-40.89%7.36M
-9.79%12.45M
27.33%13.8M
21.87%10.84M
57.00%8.89M
Selling and administrative expenses
18.07%7.83M
-0.87%6.63M
-6.71%6.69M
7.80%7.17M
291.08%6.65M
-69.75%1.7M
-10.55%5.62M
-0.90%6.29M
33.46%6.34M
90.73%4.75M
-Selling and marketing expense
48.70%291.71K
50.43%196.18K
-64.77%130.42K
-45.94%370.21K
--684.77K
----
----
----
----
----
-General and administrative expense
17.14%7.54M
-1.89%6.43M
-3.55%6.56M
13.96%6.8M
250.82%5.97M
-69.75%1.7M
-10.55%5.62M
-0.90%6.29M
33.46%6.34M
90.73%4.75M
Research and development costs
40.85%4.21M
4.86%2.99M
19.97%2.85M
-17.70%2.38M
-22.50%2.89M
-33.18%3.73M
-3.53%5.58M
46.13%5.78M
18.40%3.96M
91.81%3.34M
Depreciation amortization depletion
-18.77%35.74K
-74.99%44K
38.60%175.89K
-31.32%126.91K
23.77%184.78K
286.59%149.29K
-3.25%38.62K
37.01%39.91K
36.40%29.13K
218.33%21.36K
-Depreciation and amortization
-18.77%35.74K
-74.99%44K
38.60%175.89K
-31.32%126.91K
23.77%184.78K
286.59%149.29K
-3.25%38.62K
37.01%39.91K
36.40%29.13K
218.33%21.36K
Other operating expenses
-3.68%2.33M
34.99%2.42M
59.77%1.79M
-16.26%1.12M
-24.83%1.34M
47.04%1.78M
-28.48%1.21M
231.80%1.69M
-34.42%510.8K
-45.33%778.84K
Operating profit
-18.44%-15.49M
-2.73%-13.08M
-10.34%-12.73M
2.33%-11.54M
-60.51%-11.81M
40.89%-7.36M
9.79%-12.45M
-27.33%-13.8M
-21.87%-10.84M
-57.00%-8.89M
Net non-operating interest income (expenses)
43.75%90.02K
21.11%62.62K
644.69%51.71K
-114.22%-9.49K
-28.85%66.74K
-54.05%93.8K
41.00%204.11K
-35.20%144.76K
41.38%223.39K
3.81%158.01K
Non-operating interest income
36.55%90.9K
6.32%66.57K
517.97%62.61K
-87.72%10.13K
-21.36%82.48K
-48.62%104.88K
41.00%204.11K
-35.20%144.76K
41.38%223.39K
3.81%158.01K
Non-operating interest expense
28.24%722
11,160.00%563
--5
----
25.55%1.08K
--861
----
----
----
----
Total other finance cost
-95.42%155
-68.97%3.38K
-44.48%10.9K
33.81%19.62K
43.45%14.67K
--10.22K
----
----
----
----
Other net income (expenses)
-75.09%263.24K
-8.82%1.06M
67.44%1.16M
-38.58%692.11K
-60.51%1.13M
-21.62%2.85M
-28.85%3.64M
43.33%5.12M
-9.53%3.57M
50.20%3.95M
Other non-operating income (expenses)
-75.09%263.24K
-8.82%1.06M
67.44%1.16M
-38.58%692.11K
-60.51%1.13M
-21.62%2.85M
-28.85%3.64M
43.33%5.12M
-9.53%3.57M
50.20%3.95M
Income before tax
-22.02%-15.1M
-9.10%-12.38M
-5.74%-11.34M
-2.81%-10.73M
-144.81%-10.43M
50.25%-4.26M
-0.32%-8.57M
-21.71%-8.54M
-47.13%-7.02M
-65.63%-4.77M
Income tax
0
0
0
0
0
0
0
0
0
0
Earnings from equity interest net of tax
Net income
-22.02%-15.1M
-9.10%-12.38M
-5.74%-11.34M
-2.81%-10.73M
-144.81%-10.43M
50.25%-4.26M
-0.32%-8.57M
-21.71%-8.54M
-47.13%-7.02M
-65.63%-4.77M
Net income continuous operations
-22.02%-15.1M
-9.10%-12.38M
-5.74%-11.34M
-2.81%-10.73M
-144.81%-10.43M
50.25%-4.26M
-0.32%-8.57M
-21.71%-8.54M
-47.13%-7.02M
-65.63%-4.77M
Noncontrolling interests
Net income attributable to the company
-22.02%-15.1M
-9.10%-12.38M
-5.74%-11.34M
-2.81%-10.73M
-144.81%-10.43M
50.25%-4.26M
-0.32%-8.57M
-21.71%-8.54M
-47.13%-7.02M
-65.63%-4.77M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-22.02%-15.1M
-9.10%-12.38M
-5.74%-11.34M
-2.81%-10.73M
-144.81%-10.43M
50.25%-4.26M
-0.32%-8.57M
-21.71%-8.54M
-47.13%-7.02M
-65.63%-4.77M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019(FY)Jun 30, 2018(FY)Jun 30, 2017(FY)Jun 30, 2016
Total revenue 126.62%1.17M40.51%516.63K58.63%367.68K8.79%231.79K213.07K
Operating revenue 126.62%1.17M40.51%516.63K58.63%367.68K8.79%231.79K--213.07K--------------------
Cost of revenue 49.27%2.25M-4.97%1.51M63.37%1.59M1.19%972.47K961.02K
Gross profit -9.03%-1.08M18.67%-993.12K-64.86%-1.22M0.97%-740.69K-747.95K
Operating expense 19.22%14.41M5.00%12.08M6.60%11.51M-2.43%10.8M50.35%11.06M-40.89%7.36M-9.79%12.45M27.33%13.8M21.87%10.84M57.00%8.89M
Selling and administrative expenses 18.07%7.83M-0.87%6.63M-6.71%6.69M7.80%7.17M291.08%6.65M-69.75%1.7M-10.55%5.62M-0.90%6.29M33.46%6.34M90.73%4.75M
-Selling and marketing expense 48.70%291.71K50.43%196.18K-64.77%130.42K-45.94%370.21K--684.77K--------------------
-General and administrative expense 17.14%7.54M-1.89%6.43M-3.55%6.56M13.96%6.8M250.82%5.97M-69.75%1.7M-10.55%5.62M-0.90%6.29M33.46%6.34M90.73%4.75M
Research and development costs 40.85%4.21M4.86%2.99M19.97%2.85M-17.70%2.38M-22.50%2.89M-33.18%3.73M-3.53%5.58M46.13%5.78M18.40%3.96M91.81%3.34M
Depreciation amortization depletion -18.77%35.74K-74.99%44K38.60%175.89K-31.32%126.91K23.77%184.78K286.59%149.29K-3.25%38.62K37.01%39.91K36.40%29.13K218.33%21.36K
-Depreciation and amortization -18.77%35.74K-74.99%44K38.60%175.89K-31.32%126.91K23.77%184.78K286.59%149.29K-3.25%38.62K37.01%39.91K36.40%29.13K218.33%21.36K
Other operating expenses -3.68%2.33M34.99%2.42M59.77%1.79M-16.26%1.12M-24.83%1.34M47.04%1.78M-28.48%1.21M231.80%1.69M-34.42%510.8K-45.33%778.84K
Operating profit -18.44%-15.49M-2.73%-13.08M-10.34%-12.73M2.33%-11.54M-60.51%-11.81M40.89%-7.36M9.79%-12.45M-27.33%-13.8M-21.87%-10.84M-57.00%-8.89M
Net non-operating interest income (expenses) 43.75%90.02K21.11%62.62K644.69%51.71K-114.22%-9.49K-28.85%66.74K-54.05%93.8K41.00%204.11K-35.20%144.76K41.38%223.39K3.81%158.01K
Non-operating interest income 36.55%90.9K6.32%66.57K517.97%62.61K-87.72%10.13K-21.36%82.48K-48.62%104.88K41.00%204.11K-35.20%144.76K41.38%223.39K3.81%158.01K
Non-operating interest expense 28.24%72211,160.00%563--5----25.55%1.08K--861----------------
Total other finance cost -95.42%155-68.97%3.38K-44.48%10.9K33.81%19.62K43.45%14.67K--10.22K----------------
Other net income (expenses) -75.09%263.24K-8.82%1.06M67.44%1.16M-38.58%692.11K-60.51%1.13M-21.62%2.85M-28.85%3.64M43.33%5.12M-9.53%3.57M50.20%3.95M
Other non-operating income (expenses) -75.09%263.24K-8.82%1.06M67.44%1.16M-38.58%692.11K-60.51%1.13M-21.62%2.85M-28.85%3.64M43.33%5.12M-9.53%3.57M50.20%3.95M
Income before tax -22.02%-15.1M-9.10%-12.38M-5.74%-11.34M-2.81%-10.73M-144.81%-10.43M50.25%-4.26M-0.32%-8.57M-21.71%-8.54M-47.13%-7.02M-65.63%-4.77M
Income tax 0000000000
Earnings from equity interest net of tax
Net income -22.02%-15.1M-9.10%-12.38M-5.74%-11.34M-2.81%-10.73M-144.81%-10.43M50.25%-4.26M-0.32%-8.57M-21.71%-8.54M-47.13%-7.02M-65.63%-4.77M
Net income continuous operations -22.02%-15.1M-9.10%-12.38M-5.74%-11.34M-2.81%-10.73M-144.81%-10.43M50.25%-4.26M-0.32%-8.57M-21.71%-8.54M-47.13%-7.02M-65.63%-4.77M
Noncontrolling interests
Net income attributable to the company -22.02%-15.1M-9.10%-12.38M-5.74%-11.34M-2.81%-10.73M-144.81%-10.43M50.25%-4.26M-0.32%-8.57M-21.71%-8.54M-47.13%-7.02M-65.63%-4.77M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -22.02%-15.1M-9.10%-12.38M-5.74%-11.34M-2.81%-10.73M-144.81%-10.43M50.25%-4.26M-0.32%-8.57M-21.71%-8.54M-47.13%-7.02M-65.63%-4.77M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.86%
4
CNOOC
00883
+3.77%
5
SINOPEC CORP
00386
+2.61%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -